|
MTHFD1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.81279991018357E-10 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.079200E-01 |
| Stage1-vs-Stage3 |
8.784400E-01 |
| Stage1-vs-Stage4 |
9.121200E-01 |
| Stage2-vs-Stage3 |
5.020200E-01 |
| Stage2-vs-Stage4 |
5.134600E-01 |
| Stage3-vs-Stage4 |
9.716600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.91899981752897E-10 |
| Normal-vs-Asian |
1.62625468647093E-12 |
| Caucasian-vs-AfricanAmerican |
3.946400E-01 |
| Caucasian-vs-Asian |
9.159000E-01 |
| AfricanAmerican-vs-Asian |
3.661200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.865400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.499700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.212000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.455700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.799400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.851600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.881000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.901800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.019590E-01 |
| Classical-VS-Follicular |
7.10919999979964E-07 |
| Classical-VS-Other |
6.523700E-02 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
4.58260000002486E-06 |
| Tall-VS-Other |
1.480210E-02 |
| Tall-VS-Normal |
1.38866695920115E-12 |
| Follicular-VS-Other |
7.816800E-01 |
| Follicular-VS-Normal |
1.55431223447522E-15 |
| Other-VS-Normal |
1.587910E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
3.919600E-01 |
|
|
